Richard James Cote
#149,150
Most Influential Person Now
Richard James Cote's AcademicInfluence.com Rankings
Richard James Cotemedical Degrees
Medical
#2848
World Rank
#3289
Historical Rank
Oncology
#185
World Rank
#191
Historical Rank
Richard James Cotebiology Degrees
Biology
#11030
World Rank
#14404
Historical Rank
Pathology
#148
World Rank
#272
Historical Rank
Download Badge
Medical Biology
Why Is Richard James Cote Influential?
(Suggest an Edit or Addition)Richard James Cote's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. (2006) (3857)
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. (2007) (1419)
- Bioassay of prostate-specific antigen (PSA) using microcantilevers (2001) (976)
- Accumulation of nuclear p53 and tumor progression in bladder cancer. (1994) (791)
- Two molecular pathways to transitional cell carcinoma of the bladder. (1994) (630)
- Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. (2007) (596)
- Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype (2006) (541)
- Antigen Retrieval Immunohistochemistry: Past, Present, and Future (1997) (512)
- Detection and clinical importance of micrometastatic disease. (1999) (505)
- p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. (1993) (486)
- Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. (1991) (463)
- Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. (1995) (439)
- Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells (2010) (437)
- 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood (2011) (418)
- Origin of nanomechanical cantilever motion generated from biomolecular interactions. (2001) (409)
- Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials. (2014) (365)
- Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. (1998) (363)
- Complementary detection of prostate-specific antigen using In2O3 nanowires and carbon nanotubes. (2005) (348)
- Cantilever-based optical deflection assay for discrimination of DNA single-nucleotide mismatches. (2001) (340)
- Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. (1998) (340)
- Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. (1997) (326)
- Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. (1995) (315)
- Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. (1993) (313)
- Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. (1998) (312)
- Prognostic markers in bladder cancer: a contemporary review of the literature. (1998) (287)
- Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques (1994) (277)
- Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. (2006) (272)
- DNA Extraction from Archival Formalin-fixed, Paraffin-embedded Tissue Sections Based on the Antigen Retrieval Principle: Heating Under the Influence of pH (2002) (257)
- Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. (2004) (255)
- Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer. (2014) (250)
- p53 and treatment of bladder cancer (1997) (237)
- Real-Time, Label-Free Detection of Biological Entities Using Nanowire-Based FETs (2008) (225)
- Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. (1998) (218)
- Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. (2008) (216)
- Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival. (2007) (209)
- Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status. (2011) (206)
- Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy (2008) (199)
- Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. (2011) (195)
- Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles (2016) (191)
- Label-free, electrical detection of the SARS virus N-protein with nanowire biosensors utilizing antibody mimics as capture probes. (2009) (184)
- Molecular pathogenesis and diagnostics of bladder cancer. (2009) (182)
- Generation of human monoclonal antibodies reactive with cellular antigens. (1983) (168)
- Review of Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist: (1986) (163)
- DNA extraction from archival formalin-fixed, paraffin-embedded tissues: heat-induced retrieval in alkaline solution (2004) (162)
- Expression of Stress Response Protein Grp78 Is Associated with the Development of Castration-Resistant Prostate Cancer (2006) (161)
- CORRIGENDUM: Separable Bilayer Microfiltration Device for Viable Label-free Enrichment of Circulating Tumour Cells (2015) (156)
- Comparative study of antigen retrieval heating methods: microwave, microwave and pressure cooker, autoclave, and steamer. (1996) (154)
- Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. (2010) (153)
- Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens. (1995) (151)
- Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. (1996) (149)
- Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer (2015) (140)
- Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer. (2015) (138)
- Antigen Retrieval Techniques (2001) (136)
- Interactions between Adipocytes and Breast Cancer Cells Stimulate Cytokine Production and Drive Src/Sox2/miR-302b-Mediated Malignant Progression. (2016) (133)
- Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. (1995) (129)
- Her-2/neu expression in prostate cancer: high level of expression associated with exposure to hormone therapy and androgen independent disease. (2001) (128)
- Monoclonal Antibodies Detect Occult Breast Carcinoma Metastases in the Bone Marrow of Patients with Early Stage Disease (1988) (125)
- p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer. (2007) (125)
- Immunohistochemistry (2009) (124)
- Label-free protein recognition two-dimensional array using nanomechanical sensors. (2008) (122)
- Lower urinary tract reconstruction following cystectomy in women using the Kock ileal reservoir with bilateral ureteroileal urethrostomy: initial clinical experience. (1994) (113)
- Detection of Occult Bone Marrow Micrometastases in Patients with Operable Lung Carcinoma (1995) (112)
- A calibration method for nanowire biosensors to suppress device-to-device variation. (2009) (110)
- Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma (1983) (110)
- Orthotopic lower urinary tract reconstruction in women using the Kock ileal neobladder: updated experience in 34 patients. (1997) (108)
- A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens. (2013) (108)
- Generation of a concise gene panel for outcome prediction in urinary bladder cancer. (2007) (106)
- Prospective pathologic analysis of female cystectomy specimens: risk factors for orthotopic diversion in women. (1999) (101)
- Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. (1991) (101)
- Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. (1991) (99)
- Separable Bilayer Microfiltration Device for Viable Label-free Enrichment of Circulating Tumour Cells (2014) (98)
- Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer (2004) (91)
- Antigen Retrieval Technique: A Novel Approach to Immunohistochemistry on Routinely Processed Tissue Sections (1996) (91)
- Molecular markers for bladder cancer: the road to a multimarker approach (2007) (91)
- Circulating tumor cells: from bench to bedside. (2013) (86)
- Antigen retrieval for immunohistochemistry status and need for greater standardization (1996) (85)
- Evaluation of the Value of Frozen Tissue Section Used as “Golden Standard” for Immunohistochemistry (2007) (85)
- Modern Surgical Pathology (2009) (84)
- p53 and retinoblastoma pathways in bladder cancer (2007) (83)
- Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles. (2010) (83)
- Disseminated and circulating tumor cells: Role in effective cancer management. (2011) (82)
- DEVELOPMENT OF AN OPTIMAL PROTOCOL FOR ANTIGEN RETRIEVAL: A ‘TEST BATTERY’ APPROACH EXEMPLIFIED WITH REFERENCE TO THE STAINING OF RETINOBLASTOMA PROTEIN (pRB) IN FORMALIN‐FIXED PARAFFIN SECTIONS (1996) (81)
- Reproducibility of p53 Immunohistochemistry in Bladder Tumors (2000) (79)
- Importance of controlling nanotube density for highly sensitive and reliable biosensors functional in physiological conditions. (2010) (79)
- Genetic and Molecular Markers of Urothelial Premalignancy and Malignancy (2000) (78)
- Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. (2006) (76)
- Rapid, label-free, electrical whole blood bioassay based on nanobiosensor systems. (2011) (75)
- Standardization of immunohistochemistry based on antigen retrieval technique for routine formalin-fixed tissue sections (1998) (74)
- Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. (1995) (74)
- Detection and measurement of occult disease for the prognosis of solid tumors. (2003) (74)
- The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer (2006) (74)
- p53 expression in patients with advanced urothelial cancer of the urinary bladder (2010) (74)
- Molecular screening for bladder cancer: progress and potential (2010) (72)
- Sensitivity and detection efficiency of a novel two-step detection system (PowerVision) for immunohistochemistry (1999) (72)
- Fourier ptychographic microscopy for filtration-based circulating tumor cell enumeration and analysis (2014) (71)
- 25-Year Experience in the Management of Invasive Bladder Cancer by Radical Cystectomy (1998) (70)
- The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels. (1998) (68)
- Microscopic and gross extravesical extension in pathological staging of bladder cancer. (2004) (66)
- Molecular staging of bladder cancer (2005) (66)
- Changes in cell surface glycoprotein expression during differentiation of human keratinocytes. (1987) (66)
- Intraoperative detection of occult colon cancer micrometastases using 125I‐radiolabeled monoclonal antibody CC49 (1996) (64)
- Prognostic value of cell-cycle regulation biomarkers in bladder cancer. (2012) (63)
- High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis. (2009) (62)
- Occult metastases in lymph nodes predict survival in resectable non-small-cell lung cancer: report of the ACOSOG Z0040 trial. (2011) (62)
- Specificity analysis of human monoclonal antibodies reactive with cell surface and intracellular antigens. (1986) (60)
- Molecular biology of bladder cancer: prognostic and clinical implications. (2006) (58)
- p53 predictive value for pT1-2 N0 disease at radical cystectomy. (2009) (58)
- Highly scalable, uniform, and sensitive biosensors based on top-down indium oxide nanoribbons and electronic enzyme-linked immunosorbent assay. (2015) (55)
- ACOSOG Z0010: A multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0 breast cancer. (2010) (55)
- Therapeutic approaches to bladder cancer: identifying targets and mechanisms. (2003) (53)
- Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system. (1989) (52)
- Progress in circulating tumor cell capture and analysis: implications for cancer management (2012) (52)
- Carcinomas of Bartholin's gland. Histogenesis and the etiological role of human papillomavirus. (1993) (51)
- Incidence of occult lymph node metastases in pathological stage C (pT3N0) prostate cancer. (1995) (50)
- Molecular determinants of outcome in bladder cancer. (1999) (49)
- Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer. (1997) (48)
- Use of pH 9.5 Tris-HCl buffer containing 5% urea for antigen retrieval immunohistochemistry. (1996) (46)
- Immunopathology of adrenal and renal cortical tumors. Coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex. (1990) (46)
- Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the Bladder. (2016) (46)
- Prediction of unusual postoperative results by urodynamic testing in benign prostatic hyperplasia. (1981) (45)
- Molecular targets and targeted therapies in bladder cancer management (2008) (45)
- Calcium-induced Modification of Protein Conformation Demonstrated by Immunohistochemistry: What Is the Signal? (1999) (44)
- Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers. (2012) (43)
- Novel Immunofluorescence Protocol for Multimarker Assessment of Putative Disseminating Breast Cancer Stem Cells (2011) (43)
- Antigen Retrieval Technique (2017) (42)
- Strategies for molecular expression profiling in bladder cancer (2009) (42)
- Antigen retrieval immunohistochemistry and molecular morphology in the year 2001. (2001) (41)
- Identification and Quantitation of Circulating Tumor Cells. (2017) (41)
- Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial (2015) (41)
- Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer. (2000) (41)
- Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma (1994) (40)
- Antigen Retrieval Immunohistochemistry and Molecular Morphology in the Year 2001 (2001) (39)
- Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue. (1996) (38)
- Detection of occult metastases in lung carcinomas: Progress and implications for lung cancer staging (1998) (38)
- Antigen retrieval using pH 3.5 glycine-HCl buffer or urea solution for immunohistochemical localization of Ki-67. (1994) (38)
- ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo. (2007) (37)
- Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression. (2002) (36)
- Antigen Retrieval Immunohistochemistry: Practice and Development (1997) (35)
- Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation (2018) (35)
- Intra-observer reproducibility of whole slide imaging for the primary diagnosis of breast needle biopsies (2014) (33)
- Micrometastasis: detection methods and clinical importance. (2010) (33)
- Standardization and further development of antigen retrieval immunohistochemistry: Strategies and future goals (1999) (33)
- Size-based enrichment technologies for CTC detection and characterization. (2012) (33)
- Reproducibility of p53 immunohistochemistry in bladder tumors. National Cancer Institute, Bladder Tumor Marker Network. (2000) (31)
- Biomarker profiling for cancer diagnosis, prognosis and therapeutic management. (2005) (31)
- Steroid hormone induction and expression patterns of L-plastin in normal and carcinomatous prostate tissues. (1997) (31)
- Combination of molecular alterations and smoking intensity predicts bladder cancer outcome (2013) (30)
- Immunohistochemical markers of prognostic value in surgical pathology. (1997) (29)
- Role of coordinated molecular alterations in the development of androgen‐independent prostate cancer: an in vitro model that corroborates clinical observations (2006) (29)
- p53 protein and gene alterations in pathological stage C prostate carcinoma. (1997) (29)
- Sensitivity and reproducibility of standardized-competitive RT-PCR for transcript quantification and its comparison with real time RT-PCR (2004) (29)
- Genetic and epigenetic analysis of putative breast cancer stem cell models (2013) (28)
- The significance of intraoperative periportal lymph node metastasis identification in patients with colorectal carcinoma (1995) (28)
- Antigen retrieval immunohistochemistry used for routinely processed celloidin-embedded human temporal bone sections: standardization and development. (1998) (27)
- Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies1 (2001) (26)
- Expression profiling for bladder cancer: strategies to uncover prognostic factors (2010) (26)
- Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer. (1998) (24)
- Long‐term outcome in patients with a Gleason score ≤6 prostate cancer treated by radical prostatectomy (2011) (24)
- A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine. (2013) (23)
- Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials (2021) (22)
- The International Bladder Cancer Bank: proposal for a new study concept. (2004) (21)
- Detection of occult metastasis in patients with breast cancer. (2001) (21)
- A surface acoustic wave biosensor for interrogation of single tumour cells in microcavities. (2016) (21)
- Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients (2017) (21)
- Significance of lymphovascular invasion in organ‐confined, node‐negative urothelial cancer of the bladder: data from the prospective p53‐MVAC trial (2015) (20)
- Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer. (1984) (20)
- Promoter hypermethylation: a new therapeutic target emerges in urothelial cancer. (2005) (20)
- Benign ectopic prostatic tissue involving the seminal vesicle in a patient with prostate cancer: recognition and implications for staging. (1996) (20)
- Thermoresponsive release of viable microfiltrated Circulating Tumor Cells (CTCs) for precision medicine applications. (2015) (20)
- CHAPTER 31 – Bladder and Urethra (2009) (19)
- Opioid Prescribing Practices and Training Needs of Québec Family Physicians for Chronic Noncancer Pain (2017) (19)
- Occult metastasis. (2001) (18)
- Unusual extraskeletal myxoid chondrosarcoma in a child (1990) (18)
- Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies. (2001) (17)
- Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment (2019) (17)
- Role of genetic and expression profiling in pharmacogenomics: the changing face of patient management. (2002) (16)
- Searching for novel therapeutics and targets: insights from clinical trials. (2007) (16)
- Concepts for banking tissue in urologic oncology--the International Bladder Cancer Bank. (2005) (14)
- A Modified Reduced-Temperature Antigen Retrieval Protocol Effective for Use With a Polyclonal Antibody to Cyclooxygenase-2 (PG 27) (2002) (14)
- Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen. (1988) (14)
- The Effect of Finasteride on the Prostate Gland in Men With Elevated Serum Prostate-Specific Antigen Levels (1999) (14)
- Classical pathology versus molecular pathology in renal cell carcinoma (2007) (13)
- The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer. (2007) (13)
- LM-PCR Permits Highly Representative Whole Genome Amplification of DNA Isolated From Small Number of Cells and Paraffin-Embedded Tumor Tissue Sections (2004) (13)
- Circulating tumor cell (CTC) counts and CTC telomerase activity (TA) as prognotic markers of overall survival (OS) in SWOG S0421: Docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer (mCRPC). (2012) (13)
- Understanding PSA and its derivatives in prediction of tumor volume: addressing health disparities in prostate cancer risk stratification (2017) (12)
- Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities (2021) (11)
- Tissue distribution and cellular location of the antigens recognized by human monoclonal antibodies 16.88 and 28A32. (1988) (11)
- Occult metastases: real harm or false alarm? (2003) (11)
- Comprar Modern Surgical Pathology, 2nd Edition 2-Volume Set, Expert Consult - Online & Print | Noel Weidner | 9781416039662 | Saunders (2009) (11)
- Urodynamics studies in benign prostatic hypertrophy. (1979) (10)
- Technologies and methods used for the detection, enrichment and characterization of cancer stem cells. (2010) (10)
- The Generation of Human Monoclonal Antibodies and Their Use in the Analysis of the Humoral Immune Response to Cancer (1985) (10)
- Do Black NonHispanic Men Produce Less Prostate Specific Antigen in Benign Prostate Tissue or Cancer Compared to White NonHispanic Men with Gleason Score 6 (Grade Group 1) Prostate Cancer? (2016) (10)
- Average Weight of Seminal Vesicles (2015) (10)
- Modern Surgical Pathology (2 Volume Set) (2002) (9)
- Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas. (2017) (9)
- Modern Surgical Pathology (2 Volume Set) (2002) (9)
- Pathological possibilities and pitfalls in detecting aggressive bladder cancer (2012) (9)
- Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ‐confined, node‐negative urothelial carcinoma of the bladder (2015) (8)
- Genetic Alterations of the p 53 Gene Are a Feature of Malignant Mesotheliomas 1 (1991) (8)
- Clinical translation of a novel microfilter technology Capture, characterization and culture of circulating tumor cells (2013) (8)
- COMBINATION OF CELL CYCLE REGULATING BIO-MARKERS IMPROVES PROGNOSIS IN PATIENTS WITH ORGAN CONFINED UROTHELIAL CANCER AT RADICAL CYSTECTOMY (2008) (8)
- Using genetic programming to classify node positive patients in bladder cancer (2006) (8)
- Detection of occult metastases (1995) (7)
- Counterpoint: Both immunohistochemistry and fluorescence in situ hybridization play important roles for HER2 evaluation. (2011) (7)
- Breast carcinoma presenting as mammographic microcalcifications in axillary lymph nodes (1995) (7)
- Rhabdomyosarcoma of the liver associated with long-term oral contraceptive use. Possible role of estrogens in the genesis of embryologically distinct liver tumors. (1990) (7)
- Affinity-Based Enrichment of Circulating Tumor Cells (2016) (7)
- CHAPTER 5 Immunohistochemistry (2009) (6)
- Molecular signatures that predict nodal metastasis in bladder cancer: does the primary tumor tell tales? (2011) (6)
- REVIEW Detection and Clinical Importance of Micrometastatic Disease (1999) (5)
- 560 COMBINATION OF MOLECULAR ALTERATIONS AND SMOKING INTENSITY PREDICTS BLADDER CANCER OUTCOME: A REPORT FROM THE LOS ANGELES CANCER SURVEILLANCE PROGRAM (2012) (5)
- A novel 3D micro membrane filtration device for capture viable rare circulating tumor cells from whole blood (2008) (5)
- Advances in the pathologic staging of lung cancer: detection of regional and systemic occult metastases. (1996) (5)
- Size-Based and Non-Affinity Based Microfluidic Devices for Circulating Tumor Cell Enrichment and Characterization (2016) (5)
- Human-derived osteoblast-like cells and pericyte-like cells induce distinct metastatic phenotypes in primary breast cancer cells (2020) (5)
- Significance of Studying Circulating Tumor Cells (2016) (4)
- Prostate Cancer: From Genomics to the Whole Body and Beyond (2017) (4)
- Human monoclonal antibodies recognizing intermediate filament (IF) molecules (1984) (4)
- Reproducibility of p 53 Immunohistochemistry in Bladder Tumors 1 (2000) (4)
- Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project. (2021) (4)
- Perspectives on the Functional Characterization and In Vitro Maintenance of Circulating Tumor Cells (2016) (3)
- Acute aortic dissection. An historical review. (1982) (3)
- LEA.135 expression: An independent and favorable prognostic biomarker for patients with primary invasive breast cancer (2000) (3)
- Prevention of prostate cancer with finasteride. (2003) (3)
- Identi fi cation of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer (2015) (3)
- A sialoglycoprotein (LEA.135) associated with favourable prognosis of patients with lymph node-negative primary breast carcinoma. (1996) (3)
- Suprasellar germinoma in three lake whitefish (Coregonus clupeaformis) (2000) (3)
- Abstract 2372: Capture and molecular characterization of CTC in metastatic breast, prostate, colorectal, and renal cancer (2012) (3)
- Circulating tumor cell capture from whole blood by parylene filter devices (2005) (3)
- Immunofluorescent monoclonal antibody mab detection of bone marrow micrometastases bmm in patients with unilateral stages i iii invasive breast cancer (1990) (3)
- Immunofluorescent monoclonal antibody detection of breast cancer micrometastases (1989) (2)
- Communication between the pathologist and urologist. Focus on prostate cancer. (1995) (2)
- Risk Factors and Molecular Features Associated with Bladder Cancer Development (2018) (2)
- Complete p53 multi-exon sequencing by gene chip complements use of p53 immunohistochemistry for prediction of clinical outcome in invasive bladder cancer (2004) (2)
- VARIABILITY IN SURGICAL QUALITY IN A RANDOMIZED CLINICAL TRIAL OF ADJUVANT CHEMOTHERAPY FOLLOWING RADICAL CYSTECTOMY AND PELVIC LYMPHADENECTOMY (2009) (2)
- LEA.135 expression: its comparison with other prognostic biomarkers for patients with primary breast carcinoma. (2000) (2)
- Supplementary Information (SI) (2010) (2)
- Immunofluorescent monoclonal antibody detection of breast cancer bone marrow micrometastases in patients with unilateral invasive breast cancer Distribution by TNM stage (1992) (2)
- Circulating tumor cell kinetics in mRCC patients treated with sunitinib (2014) (2)
- Is the Signal? Calcium-induced Modification of Protein Conformation Demonstrated by Immunohistochemistry: What (2013) (2)
- Fourier Ptychographic Microscopy for Rapid, High-Resolution Imaging of Circulating Tumor Cells Enriched by Microfiltration. (2017) (2)
- Reporting the Capture Efficiency of a Filter-Based Microdevice: A CTC Is Not a CTC Unless It Is CD45 Negative—Response (2011) (2)
- Re: Reconsideration of the clinical and histopathological significance of angiogenesis in prostate cancer: Usefulness and limitations of microvessel density measurement (2016) (2)
- Diagnostic 'individuality'. (2001) (2)
- Circulating tumor cell capture and analysis in a multicenter SWOG-coordinated prostate cancer trial. (2010) (2)
- Results of telomerase activity measurements from live circulating tumor cells captured on a slot microfilter in a phase III SWOG-coordinated prostate cancer trial (S0421). (2012) (1)
- Abstract LB-193: Separable bilayer microfiltration device for viable label-free enrichment of circulating tumor cells (2014) (1)
- Serological Dissection of Human Breast Cancer with Mouse and Human Monoclonal Antibodies (1985) (1)
- Analysis of the Humoral Immune Repertoire in Patients with Cancer (1987) (1)
- Pathologic Assessment of Bladder Cancer and Pitfalls in Staging (2001) (1)
- Defining a nine-biomarker panel for predicting bladder cancer outcome in combination with smoking intensity: A report from the Los Angeles Cancer Surveillance Program. (2012) (1)
- Genetic and epigenetic analysis of putative breast cancer stem cell models (2013) (1)
- Top-down fabricated polysilicon nanoribbon biosensor chips for cancer diagnosis (2013) (1)
- PREDICTORS OF RECURRENCE IN PATIENTS WITH LOW VOLUME LYMPH NODE DISEASE FOLLOWING RADICAL CYSTECTOMY (2008) (1)
- Nucleic acids in disease prognosis. (2001) (1)
- Circulating Tumor Cells: Where From Here? (2015) (1)
- In Search of Gentle Death: The Fight for Your Right to Die With Dignity (2012) (1)
- Prevalence of putative breast cancer stem cells (BCSC) in lymph node occult metastases (LNOM) of patients with node-negative (LN-) breast cancer (BC) (2008) (1)
- Phase III Trial Assessing 3 Cycles of MVAC in Organ-Confined Bladder Cancer with p53 (2004) (1)
- Cellular proliferation and cell-cell cycle regulatory proteins as prognostic markers for transitional cell carcinoma of the bladder. (1999) (1)
- Early Changes in Circulating Tumor Cells and Free Circulating DNA in Men Treated for Prostate Cancer: Contrasting Primary Versus Salvage Treatment (2015) (1)
- 576: Patient Randomization Factors in the P53 Targeted Therapy Trial in Bladder Cancer (SWOG 4B951) (2007) (1)
- 1276 A NOVEL PRECISION-ENGINEERED MEMBRANE MICROFILTRATION DEVICE FOR CAPTURE AND CHARACTERIZATION OF BLADDER CANCER CELLS IN URINE (2012) (1)
- Immune response of cancer patients: Analysis with human monoclonal antibodies (1984) (1)
- Circulating tumor cell counts (CTC) as prognostic of overall survival (OS) in SWOG S0421-docetaxel with or without atrasentan for metastatic castration resistant prostate cancer (mCRPC). (2012) (1)
- Reply from Authors re: Joseph L. Chin. In Search of the Perfect Crystal Ball for Ta Urothelial Cancer. Eur Urol 2010;57:21–2 (2010) (1)
- Nanomechanical Sensor Array for Detection of Biomolecular Bindings: Toward a Label-Free Clinical Assay for Serum Tumor Markers (2004) (1)
- Prognosis of Minimal Residual Disease in Bone Marrow, Blood and Lymph Nodes in Breast Cancer (2003) (1)
- Detection of circulating tumor cells in advanced renal cell carcinoma patients using microfilter-based capture (2012) (1)
- Targeting Autophagy in Cancer Therapy. (2017) (1)
- Adrenal cortical carcinoma associated with a splenic vein tumor thrombus. (1998) (1)
- MULTIPLE BIO-MARKERS FOR THE PREDICTION OF BLADDER CANCER RECURRENCE AND MORTALITY (2008) (1)
- Occult metastases in patients with breast cancer. (2001) (1)
- Re: Joseph Chin. In Search of the Perfect Crystal Ball for Ta Urothelial Cancer. Eur Urol. doi:10.1016/j.eururo.2009.09.014. (2009) (1)
- Development of a novel micromachined parylene membrane filter device for capture and characterization of circulating tumor cells from peripheral blood. (2006) (0)
- 542 IMPROVED PREDICTION OF CLINICAL OUTCOMES IN PATIENTS WITH ADVANCED BLADDER CANCER USING A PANEL OF FOUR CELL CYCLE REGULATORS (2009) (0)
- Molecular staging of cancer (2000) (0)
- Circulating Tumor Cells: Enrichment and Genomic Applications (2018) (0)
- Prognostic Factors in Bladder Cancer: Emphasis on Immunohistochemical Analysis (1998) (0)
- 58 Significance of occult metastases to the lymph nodes in patients with prostate cancer. Results from a long term follow up study (2004) (0)
- Contrasting Circulating Tumor Cells and Free Circulating DNA Responses in Men Treated for Prostate Cancer after Primary Versus Salvage Radiotherapy (2020) (0)
- MULTI-INSTITUTIONAL EVALUATION OF THE PREDICTIVE VALUE OF P53 IMMUNOHISTOCHEMICAL STAINING IN PATIENTS WITH PT1-2 N0 DISEASE AT RADICAL CYSTECTOMY (2008) (0)
- Nanosensing applications of In2O3 nanowires and carbon nanotubes (2005) (0)
- racterization of Circulating Tumor Cells (2010) (0)
- ln vited Revie w Histology and Histopathology lmmunohistochemical markers of prognostic value in surgical pathology (2010) (0)
- Serial blood draws in metastatic breast cancer patients undergoing systemic treatment analysed by size based CTC detection and mFAST Seq cell free DNA analysis (2017) (0)
- Reply to O. Dizdar et al (2012) (0)
- P1-12 A Modified Reduced Temperature Antigen Retrieval Protocol That Is Effective For Use With A Polyclonal Antibody to Cyclooxygenase-2 (PG 27) (2002) (0)
- Abstract 4702: Effects of smoking on the molecular pathology of urinary bladder cancer and its prognostic importance (2010) (0)
- A CONCISE 4-GENE PANEL CAN PREDICT CLINICAL OUTCOME IN URINARY BLADDER CANCER (2009) (0)
- Technical Advances High Quality Assessment of DNA Methylation in Archival Tissues from Colorectal Cancer Patients Using Quantitative High-Resolution Melting Analysis (2009) (0)
- Pathologic quiz case: a 41-year-old woman with bilateral nodular breasts. (2002) (0)
- A tribute to Edward J. Beattie, Jr. (1998) (0)
- Association of Circulating Tumor Cells (CTCs) and Genomic Signatures in Prostate Cancer Patients (2018) (0)
- 887 USING ARTIFICIAL INTELLIGENCE AND MACHINE-LEARNING ALGORITHMS WITH GENE EXPRESSION PROFILING TO PREDICT SUPERFICIAL BLADDER CANCER RECURRENCE AT INITIAL PRESENTATION (2012) (0)
- Capture and characterization of disseminated tumor cells in bone marrow, blood, and lymph nodes of patients with cancer: Progress and challenges (2006) (0)
- Occult metastases: Detection and prognostic and therapeutic implications (2012) (0)
- Abstract B65: Precompetitive collaboration on liquid biopsy for early cancer assessment (2020) (0)
- Antibody Reactivity to Cell Surface and IntraceUular Antigens (2003) (0)
- Comparison of p53 genotype and phenotype: Site of mutation predicts outcome in patients with bladder cancer (2005) (0)
- Affi nity-Based Enrichment of Circulating Tumor Cells (2019) (0)
- Abstract 1447: Capture, culture and characterization of viable circulating tumor cells in a syngeneic breast cancer mouse model system. (2013) (0)
- Antigenic masking: modification of a tumor cell surface antigen (OM5) by progressive sialylation (1985) (0)
- THE COMBINED EFFECTS OF p53, p21, and Rb EXPRESSION IN BLADDER CANCER PROGRESSION (1999) (0)
- LONG-TERM OUTCOME OF PATIENTS WITH GLEASON ≤6 TREATED BY RADICAL PROSTATECTOMY (2008) (0)
- Abstract 5254: RNA extraction and gene expression profiling in circulating tumor cells (CTC) using a sized-based method for CTC capture (2011) (0)
- CHAPTER 3 – The Surgical Pathology Report (2009) (0)
- Clinical Cancer esearch ing , Diagnosis , Prognosis table Filter-Based Microdevice for Detection and R racterization of Circulating Tumor Cells (2010) (0)
- 153 DETECTION OF GASTRIN RELEASE PEPTIDE RECEPTOR ANTIGEN MARKER OF LUNG CANCER MICROMETASTASIS IN PERIPHERAL BLOOD USING QUANTITATIVE COMPETITIVE REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION HYBRIDIZATION ASSAY. (2004) (0)
- Standardization of Routine Immunohistochemistry (IHC) by Antigen Retrieval (AR): is it Possible? (1997) (0)
- The effect of p21waf1/iip1 expression and tumor progression in bladder cancer john p. stein, david a. ginsberg (1997) (0)
- Prognostic impact of tumor fractions in plasma assessed with mFAST-SeqS on overall survival of metastatic breast cancer undergoing systemic treatment (2018) (0)
- Chapter 17 Human Monoclonal Antibodies Humoral Immune Response in Patients with (1985) (0)
- Progress in circulating tumor cell capture and ana lysis: implications for cancer (2012) (0)
- Specificity analysis of two new mouse monoclonal antibodies reactive with prostate cancer (1987) (0)
- Physician Prescription Practices and Training Needs Questionnaire (2018) (0)
- Circulating Tumor Cells (CTCs) in Advanced Lung Cancer: Prognostic Impact of Quantification and Morphology by 2 Separate Techniques (2014) (0)
- Editorial: Prostate Cancer: What We Know and What We Would Like to Know (2015) (0)
- Correlation Between MRI-Derived Quantitative Biomarkers and Circulating Tumor Cells in Prostate Cancer (2015) (0)
- Detection of Early Tumor Dissemination in Patients With Breast Cancer (2006) (0)
- 962 MOLECULAR ALTERATIONS IN BLADDER CANCER ASSOCIATED WITH CARCINOGEN EXPOSURE AND THEIR PROGNOSTIC IMPACT: A LOS ANGELES COUNTY EXPERIENCE (2010) (0)
- MANAGEMENT OF URETERAL STRICTURES FOLLOWING INDIANA POUCH RECONSTRUCTION AT THE TIME OF ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL CYSTECTOMY (2011) (0)
- Molecular detection of micrometastatic breast cancer in histopathology - Negative axillary lymph nodes fails to predict breast cancer recurrence: A final analysis of a prospective multi-institutional cohort study (2011) (0)
- Diagnostic 'individuality' [1] (2001) (0)
- In Search of the Perfect Crystal Ball for Ta Urothelial Cancer (2010) (0)
- Quantitative transcriptional profiling of cell survival and cell death genes in cultured bladder cancer cells (2002) (0)
- 1653 AN ANGIOGENESIS-MARKER PANEL PREDICTS NONINVASIVE PAPILLARY BLADDER CANCER RECURRENCE AT INITIAL PRESENTATION (2011) (0)
- Automatic detection of circulating tumor cells and cancer associated fibroblasts using deep learning (2023) (0)
- Editorial comment. (2010) (0)
- Characterization of a human monoclonal antibody (hmAb) (EV248) reactive with an apparently tumor-restricted differentiation antigen (1985) (0)
- Abstract P6-05-01: Interactions between adipocytes and breast cancer cells stimulate cytokine production and drive Src/SOX2/miR-302b mediated malignant progression (2018) (0)
- p 53 Bladder Cancer Progression and Has Cooperative Effects with Elevated and Absent pRb Expression Is Associated with Updated (2006) (0)
- Abstract 2258: Using molecular alterations to predict bladder cancer prognosis independent of clinicopathologic parameters and cigarette smoke exposure (2011) (0)
- The Combination of Multiple Cell Cycle Regulators Improves Prognosis in Patients with Pathologic Organ-Confined Bladder Cancer: A Multicenter External Validation Study (2010) (0)
- Generation of human monoclonal a cellular antigens (hybridoma/cell-surface antigens/intracellular antigens/cancer imnm (2016) (0)
- 1057 PROTEIN ALTERATIONS PREDICT BLADDER CANCER OUTCOME INDEPENDENT OF CLINICOPATHOLOGIC PROGNOSTIC CRITERIA AND TOBACCO SMOKE EXPOSURE (2011) (0)
- IMPROVED PREDICTION OF CLINICAL OUTCOMES IN PATIENTS WITH ADVANCED BLADDER CANCER USING A PANEL OF FOUR CELL CYCLE REGULATORS (2009) (0)
- Comparison of microfilter-based capture to CellSearch in detection of circulating tumor cells (CTCs) in patients with metastatic castration-resistant prostate cancer (mCRPCa). (2014) (0)
- Identification of Cellular and Molecular Markers of Prostate Cancer Progression in Racial-Ethnic Minorities (2002) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Richard James Cote?
Richard James Cote is affiliated with the following schools:
